Summary of Safety and Effectiveness



Similar documents
510(k) Summary of Safety and Effectiveness JUN Hip prosthesis

DEC V,(9/azO (c 0 j

February 22, Life Spine, Incorporated Mr. Randy Lewis General Manager 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169

October 28, Cavex Holland Bv Mr. Richard Woortman Manager Technical Services Fustweg 5 Haarlem, 2031CJ The NETHERLANDS

July 24, Dear Ms. Rhodes:

March 20, Dear Mr. Chen:

510(k) Summary. Dentsply Implants. April 30, 2013

Q(K SVJM~jPagelIof 3

June 9, Stryker Corporation Garry T. Hayeck, Ph.D. Senior Regulatory Affairs Specialist 2 Pearl Court Allendale, New Jersey 07401

February 5, Dear Kristin Pabst,

August 12, Oertli Instrumente AG Ms. Karin Rohr Head of Quality Management & Regulatory Affairs Hafnerwisenstrasse 4 CH 9442 Berneck Switzerland

March 3, Dear Ms. Alice Gong,

(k)Suminary k

September 25, Dear Ms. McCoy:

ATLANTIS Anterior Cervical Plate System ATLANTIS Translational Plate. 510(k) Summary. February 2007

May 7, Tactile Systems Technology Inc Daniel Chase V.P. Engineering & Operations 1331 Tyler St NE Minneapolis, Minnesota 55413

GE Healthcare MAR

January 12, Dear Amy Yang:

Simpler Implant Solutions Inc Arbutus St. Vancouver, BC V6i 3Y9. haroldbergmanl~ogmail.com Telephone Fax K080115

August 21, TCM Associates Ltd Mr. Iain Alligan Technical Director 3 Hillgrove Business Park Nazeing Road Essex EN9 2HB United Kingdom

April 7, Acclarent, Inc. Mr. James Patrick Garvey II Sr. Manager, Regulatory Affairs 1525-B O'Brien Drive Menlo Park, CA 94025

University of Texas Medical School at Houston. April 14, 2015

Lewis Ward L.W. Ward and Associates, Inc Kirkwood Court Boulder, CO

November 20, Vascular Flow Technologies Ltd. Edwin Lindsay VP of QA/RA Prospect Business Centre, Gemini Cresent Dundee DD2 1TY United Kingdom

0 EC V-,) 133 Lj9a

May 5, Dear Mr. Courtney:

Dental Morelli Ltda.

Phoenix Thera-Lase Systems, LLC Ms. Diane Rutherford Ken Block Consulting 1201 Richardson Drive, Suite 280 Richardson, Texas 75080

510(k) Summary. Atlanti STM Abutment and AtlantisTM Crown Abutment in Zirconia for Dentsply Ankylos Implant

SUMMARY OF SAFETY AND EFFECTIVENESS for Powered Muscle Stimulator

Ad-tech Medical Instrument Corporation. Principal Consultant Quality & Regulatory Associates, LLC. 800 Levanger Lane. Stoughton, Wisconsin 53589

510(k) SUMMARY MANI Needle and Suture Pack MANI, Inc.

AW Server 510 (k) Summary of Safety and Effectiveness

JUN 2 6 butt. EkoSonicTM Endovascular System with Rapid Pulse Modulation

EM GR.OUF DIPLOMAT. OT39?1 Company Name: (K)SUMMARY Oc. Submission Correspondent. Emergo Group, Inc. Company Address:

DICOM Grid, Inc. January 25, Senior Consultant Biologics Consulting Group, Inc. 400 N. Washington Street, Suite 100 ALEXANDRIA VA 22314

BMR ~131o-lvleccai Kesearcn Ltd.

Building 6, Suite 300 RyeBrook, NY C-ontact-N~ame: --- William H-. Schofield Director of TeleHealth Operations. Signal,_Radiofrequency

510(K) SUMMARY [as required by section (c)] FLIGHT 60 Ventilator 510(k) Number K IaO?2Z, JUL

Brainreader ApS February 4, 2015 C/O Mette Munch QA Consultant Skagenvej 21 Egaa, 8250 DENMARK

November 17, Nanova Biomaterials, Inc. Mr. Andrew Ritts Senior Research Scientist 3806 Mojave Ct Columbia, Missouri, 65202

510(K) SUMMARY. 510(k) Number KOS'00-r

MAY SECTION VIII. 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS

kok1 UQ 510(k)J Device {Applicant 510(k) Summary (per 21 CFR (c)) OCT Applicant

Ni Hau Industrial Co., Ltd. Ms. Lyn Chiu Sales Manager No. 15, Alley 125, Lane 318, Section 2, An Ho Road Tainan City, Taiwan 70967

Ultimate Concepts Inc.

SECTION 5 BARDEX TEMPERATURE-SENSING FOLEY CATHETER 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS INFORMATION

2. Contact Person: Garo Mimaryan, MS., RAC 7 Technical Regulatory Affairs Specialist III 3. Phone Number: (914)

Section 5-510(k) Summary. This document is provided in the following pages. DEC

May 20, Ivoclar Vivadent Ag Ms. Donna Hartnett Director Regulatory Affairs Ivoclar Vivadent, Inc. 175 Pineview Drive Amherst, New York 14228

sbchoi~kku.edu jeremy~sooil.com DANA Diabecare IlS Insulin Infusion pump Infusion pump Class II

October 29, Dear Ms. Hartnett:

510(k) Summary GlobalMedia Group, LIC. MAY CONiM

L~l t l V~! MAY ?

,11 DSA Cable, transducer and VS3, VS4 electrode, patient connector

MAY Attachment (k) Summary 21 CER

May 22, Rachel s Remedies, LLC Mrs. Rachel E. Jackson 2316 Delaware Ave. #174 Buffalo, New York 14216

Koqo8 go. ER35 ERO-SCAN Pro Hearing Test System. 61 Martin Lane Elk Grove Village, IL Manager of Instrumentation Products

D I Z1. 510(k) Summary. Section 5. Siemens Medical Solutions USA, Inc. Oncology Care Systems. Date Prepared: September 09,

51O(K) SUMMARY: Therapy family of devices.

foq8 510(k) Summary fo r PAIRIETEX ~ COMPOSITE Mesh

DEC The three components of the Axxent Electronic Brachytherapy System include the Controller, Balloon Applicators-BR and X-ray Source.

OCT 18 20U5Ibko. a. Submitter Name: Cosmetic Dental Materials Inc. (CDM Inc.) b. Submitter Address: 812 Water St. NE Albany OR 97321

Datrix, Inc NOV Appendix G. 510(k) Summary of Safety and Effectiveness for Datrix, Inc CardioServer ECG Management System

MViAKIO. V.A hn2 ATTACHMENT I 610(K) SUMMARY. Submitter:

Dear Ms. Lucas: This letter corrects our substantially equivalent letter of February 18, 2016.

ItP. Section I. 510(k) Summary of Safety and Effectiveness. Applicant:

JN (k) Summary Device Identification: Device Description:

March 31, Etiometry, Inc. Richard Galgon Independent Consulting Associate Quintiles 5846 Cobblestone Lane Waunakee, Wisconsin 53597

Food and Drug Administration 5 10(k) Notijfication - Partial & Total Ossicular Replacement Prostheses AUG I June 30, 2006

510(k) SUMMARY APR Date: 15 th December 2008

Fresenius Medical Care

510(k) Summary (c)

RAMSOFT BUG ,-. I"-, --I 2 N Tel: (416) Fax: (416) sales@ramsoftbiz (k) Summary

KIZ 2,33-3 p8 ~ 510(k) Summary. As required by 21 CFR (c) 510(k) Premarket Notification Submission AFrame Digital MobileCare Monitor.

AgaMatrucx. NV2 21 Salem, NH oz (k) Sumnmary

510(k) Summary Special Premarket Notification 510(k) Section 6

July 21, Dentca, Inc. c/o Mr. Claude Berthoin Denterprise International, Inc. 110 East Granada Blvd, Suite 207 Ormond Beach, Florida 32176

Manufacturing Technology, Inc.

March 23, Vision Quest Industries, Inc. Mr. Mohammed Ouerghi Director of QA/RA 1390 Decision Street, Suite A Vista, CA 92081

Histoacryl Flexible Topical Skin Adhesive April15, 2013

I C 5 5l v ri 510(K) SUMMARY. Prowess Panther

510(K) Summary K102148

r5 73~ 9/ / 510(K) Summary (K) SUMMARY

510(k) SUMMARY. OPTION-vyM Urinary Catheter

Metal-on-Metal Hip Systems

MAR (k) SUMMARY OF SAFETY AND EFFECTIVENESS (21CFR ) 1. DATE PREPARED: 4/21/2008

510(k) SUMMARY JUL Otoharmonics 0 Levo 9 System

ELASTO-GEL MANIJKAH"O"NEY JUUjj 2. fudbthsarltvl of the wound fluid, while re~leas'ing

Section (K) Summary. Kimberly-Clark Corporation Winchester Road Neenah, WI 54956

510(k) Summary. (508) X222 Disposable Insulin Delivery Device

Transcription:

Pg.1/3 Summary of Safety and Effectiveness Date: June 11, 2014 U.S. Contact Person: 0 Dr. Stephen J. Peoples Manufacturer: Principal Consultant Limacorporate S.p.A. Phone: 260-645-0327 Via Nazionale, 52 FAX: +39 0432945512 33038 - Villanova di San Daniele Udine - Italy - Podct Common Product Namuc ~ Cd ReguationandClassiflcadion'Name Hip joint metal/ceramic/polymer semiconstrained cemented or nonporous LZO uncemented prosthesis per 21 CFR 888.3353 Hip joint metal/polymer semi-constrained JDI cemented prosthesis per 21 CER Total or 888.3350 MasterS Hemi Hip joint femoral (hemi-hip) femoral stem Hip KWY metal/polymer cemented or uncemented Prosthesis prosthesis per 21 CFR 888.3390 Prosthesis, Hip, Constrained, Cemented KWZ Or Uncemented, Metal/Polymer per 21 CFR 888.3310 Prosthesis, Hip, Semi-Constrained, LPH Metal/Polymer, Porous Uncemente per 21 CER 888.3358 Description: The Master SL femoral stem is a monolithic, collarless, tapered wedge shaped stem intended for press-fit uncemented partial or total hip arthroplasty. When used in total hip arthroplasty the stem is coupled to a Limacorporate Femoral Heads (Kl 12158) and used with either a Limacorporate Cemented Cups (Ki112158) or Limacorporate Delta TT Acetabular System cup (KI 12898). When used in partial hip arthroplasty the MasterSL femoral stem is coupled to a Limacorporate Femoral Heads (Kl 12158) and used with a Lock Bipolar Head,(Limacorporate Ki 1215 8). The MasterSL femoral stem is made of Ti6AI4V alloy conforming to ASTM F1472 - ISO 5832-3; the proximinal '/2 of the stem a plasma sprayed coating of titanium alloy (ASTM F1472-1S0 5832-3). The stem has a tapered rectangular section and the distal anterior and posterior surfaces have a vertical groove for rotational stability. The stem provides a

Pg.2/3 neck with a 12/14 conical taper to couple to Limacorporate Femoral Heads and the necks are minror-polished and lowered to reduce accidental abrasion and contact between the stem neck and the acetabular cup. The MasterSL stems is available 13 sizes in both standard and lateralized versions with different CCD angles. Intended Use: The MasterS stems are indicated for use in partial or total hip arthroplasty and are intended for press-fit (uncemented) use. When used in total hip arthroplasty, the MasterSL Stems are intended for use with Co-Cr-Mo femoral heads and cemented cups or with Co-Cr-Mo femoral heads and Delta TT Acetabular System. When used in partial hip arthroplasty, the MasterSL stems are intended for use with Lock Bipolar Heads. Hip arthroplasty is intended for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: * non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis and hip dysplasia; " rheumatoid arthritis; " treatment of femoral head and neck fractures; " revisions in eases of good remaining femoral bone stock. Predicate Devices: * H-MAX S stems (Limacorporate, KI 12091): * Encore Linear Hip (DJO, K972791 and K99 1325); * Modulus Femoral Hip System (Limacorporate, K1 12158); * Taperloc 12/14 Taper Femoral Component (BIOMET, K(043537). Comparable Features to Predicate Device(s): The MasterS stems are substantially equivalent to the predicate devices in terms of intended use, indications for use, design and materials. As for all of the predicates, the MasterS stems is intended for use in total hip arthroplasty and like the Modulus Femoral Hip System predicate (KL 12158), it can also be used in partial hip arthroplasty. Like all of the predicates, the subject MasterSL stem is intended for press-fit cementless use. The MasterSL stems are manufactured from the same materials as the predicate devices. The MasterS stem has a tapered wedge design which is similar to all of the predicates exception that predicate Modulus stem is a 2-piece stem with the compon ents coupled through a conical taper while the other predicates and the subject device are all one pice monolithic stems. Like all of the predicates, the subject device is available in standard and lateralized versions, with different CCD angles, offsets and sizes. Non-Clinical Testin2: The MasterSL stems were tested in worst case configurations for fatigue resistance according to ISO 72064 and ISO 7206-6.

Fg.3/3 The ROM o,f the Master SL hip stem was analyzed using the worst case construct. The Titanium Plasma Spray coating was characterized to verify the conformity to FDA guideline and referenced standards. Clinical Testing: Clinical testing was not necessary to demonstrate substantial equivalence of the MasterSL Femoral Stem to the predicate devices.

* DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Semite S5.I #~a.food and Drug Administraton Document Control Center - W066-0609 Silver Spring. MD 20993-0002 June 10, 2014 Limacorporate S.p.A. % Stephen Peoples, VMD President Peoples and Associates Consulting LLC 50 10 Lodge Pole Lane Fort Wayne, Indiana 46814 Re: K140975 Trade/Device Name: MasterSL Femoral Stem Regulation Number: 21 CER 888.3353 Regulation Name: Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis Regulatory Class: Class 11 Product Code: LZO, JDI, KWY, KWZ, LPH Dated: February 25, 2014 Received: April 16, 2014 Dear Dr. Peoples: We have reviewed your Section 5 10(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not ev aluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class 11 (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 2 1, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical

Page 2 - Dr. Stephen Peoples device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 53 1-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7 100 or at its Internet address http://www.fda.gov/medicaldevices/resourcesfoyou/distry/default.htnil. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http)://www.fda.qov/medicaidevics/safet/reortproblem/defau lt.htin for the CDRI-'s Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7 100 or at its Internet address http):hww-w.fda.,,ov/medicaldevices/resourcsfoyot/ndustr/default.htinl. Enclosure Sincerely yours, Lori A. Wiggins for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Pg.1/. 510(k) Number (if known): K 140975 Device Name: Master SL Femoral Stem Indications for Use: MasterSb Femoral Stem Indications for Use The MasterSL stems are indicated for use in partial or total hip arthroplasty and are intended for press-fit (uncemented) use. When used in total hip arthroplasty, the Master SL Stems are intended for use with Ca-Cr-Mo femnoral heads and cemented cups or with Co-Cr-Mo, femoral heads and Delta TI' Acetabular System. When used in partial hip arthraplasty, the MasterSL stems are intended for use with Lock Bipolar Heads. Hip arthroplasty is intended for reduction or relief of pain and/or improved hip function in skeletally mature patients with the following conditions: " non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis and hip dysplasia; * rheumatoid arthritis; " treatment of femoral head and neck fractures; " revisions in cases of good remaining femoral bone stock. Prescription Use X -AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Elizabeth L. Frark&4S Division of Orthopedic Devices Page 1 of 1 Traditional 5 10(k) - Master SL Femoral Stem